ArticleArchives of microbiology2026
Alternating magnetic fields enhance growth and co-production of cellulase and protease in Bacillus velezensis fermentation.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Bacillus velezensis is a safety-grade probiotic with wide applications in agricultural, food and industrial biotechnology. Improving its growth and extracellular enzyme production is critical for enhancing process efficiency and reducing production costs. This study evaluated the potential of alternating magnetic fields (AMFs) to enhance the growth and extracellular enzyme production in B. velezensis. A preliminary comparison with static magnetic fields (SMFs) demonstrated that AMFs exerted a stronger stimulatory effect, therefore AMFs were selected for subsequent investigation. Under the optimal AMF conditions (3 mT, 18 h), biomass increased by 63.59% relative to the untreated control, while cellulase and protease activities were enhanced by 142.93% and 130.5%, respectively. Moreover, AMF treatment significantly improved enzyme stability, for example, cellulase produced under AMF-assisted fermentation retained 72.15% of its initial activity after 24 h at 37 °C when incubated under a 3 mT AMF, whereas only 19.05% activity remained under non-AMF incubation. A similar stabilization trend was observed for enzymes produced under non-AMF fermentation conditions. Scanning electron microscopy revealed that AMF treatment induced notable changes in cell surfaces, including increased roughness, pronounced folding, and depressions, potentially enhancing membrane permeability. Transcriptomic profiling further indicated significant upregulation of key metabolic pathways, specifically branched-chain amino acid biosynthesis, acetyl-CoA metabolism, and secondary metabolite biosynthesis. These results demonstrate that AMF represents a promising non-invasive strategy for enhancing microbial bioprocess performance.
Indexed as
Identifiers
41902923What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.